C-reactive Protein Testing Market (By Assay Type: Immunoturbidimetric Assay, ELISA, Chemiluminescence Immunoassay, Others; By Detection Range: hs-CRP, Conventional CRP, cCRP; By Disease Area: Cardiovascular Diseases, Cancer, Rheumatoid Arthritis, Inflammatory Bowel Disease, Endometriosis, Lupus, Others; By End-use: Clinics, Hospitals, Laboratories, Assisted Living Healthcare Facilities, Home) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

The global c-reactive protein testing market size is expected to be worth around US$ 10.6 billion by 2030, according to a new report by Vision Research Reports.

The global c-reactive protein testing market size was valued at US$ 8.5 billion in 2020 and is anticipated to grow at a CAGR of 0.6% during forecast period 2021 to 2030.

Report Coverage

Report Scope Details
Market Size USD 10.6 billion by 2030
Growth Rate CAGR of 0.6% From 2021 to 2030
Base Year 2021
Forecast Period 2021 to 2030
Segments Covered Assay type, Detection range, Disease type, End-use
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Thermo Fisher Scientific, Inc.; F. Hoffmann-La Roche Ltd; Danaher; Quest Diagnostics; Siemens Healthineers AG; Abbott; Merck KGaAA; Zoetis; Ortho Clinical Diagnostics; Getein Biotech, Inc; HORIBA, Ltd; Randox Laboratories Ltd; BODITECH MED, INC.; Aidian

Growth Factors

 The market growth can be attributed to substantial research activities to explore the applications of C-reactive protein (CRP) testing coupled with the presence of private as well as public agencies which grant funds to expedite the research proceedings in this arena.

A rise in the number of strategic deals and developments coupled with the increase in investments for R&D of C-reactive protein testing is expected to drive the market significantly. The ongoing COVID-19 pandemic has affected the CRP testing market to a great extent. As CRP is considered to be the determining biomarker for the severity of infection/inflammation, the market is witnessing increased demand for CRP testing services and products. Major operating companies such as Abbott offer supportive tools for CRP testing for SARS-CoV-2 infection.

By Assay Type Analysis

The immunoturbidimetric assays dominated the market and accounted for the largest revenue share of 48.5% in 2020. The segment is anticipated to further grow during the forecast period. 

Technological advancements in immunoturbidimetric assays are expected to fuel market growth in the coming years. Researchers across the world are actively involved in the development of advanced and innovative assays to support rapid and accurate CRP testing.

By Detection Range Analysis

The hs-CRP segment dominated the CRP testing market and accounted for the largest revenue share of 42.8% in 2020. The segment is anticipated to witness a CAGR of 0.3% from 2021 - 2028. 

American Heart Association (AHA) and Centers for Disease Control and Prevention (CDC), hs-CRP acts as an independent marker that facilitates in the estimation of cardiovascular disorders such as myocardial infarction.

By Disease Type Analysis

The Cardiovascular diseases (CVD) segment lead the market and accounted for the largest revenue share of 22.8% in 2020. An increase in the prevalence of CVDs is the major factor contributing to the growth of the market. Adoption of a sedentary lifestyle, obesity, hypertension, and diabetes are few risk factors associated with CVDs.

The cancer segment held the second-largest revenue share in 2020. It is a crucial public health burden across the globe. According to the WHO, there are more than 1.9 million deaths and 3.7 million new cancer cases every year in the European region, hence, there is a need for large-scale adoption of POC CRP testing solutions to aid in the management of cancer in developed and developing countries across the globe.

By End-use Analysis

 The hospitals segment dominated the market and lead for the largest revenue share of 31.2% in 2020. The growth of the hospitals segment can be attributed to the rising penetration of CRP testing in hospitals, especially in developing regions across the world.

The clinics segment held a substantial market share throughout the analysis period. CRP testing technology has expanded in the past few years with noteworthy developments in areas of point-of-care and hs-CRP. 

By Regional Analysis

North America dominated the C-reactive protein testing market and accounted for the highest revenue share of 40.5% in 2020. Increasing adoption of innovative, advanced technology and high focus on clinical research in North America are among the factors driving the market. 

According to the American Cancer Society, prostate cancer is the second most diagnosed cancer in the U.S. and the third leading cause of death in men. Estimates from the same source also indicated that one in 41 men in the U.S. will die as a result of prostate cancer.

Key Players 

  • Thermo Fisher Scientific, inc.

  • F. Hoffmann-La Roche Ltd.

  • Danaher

  • Quest Diagnostics

  • Siemens Healthineers AG

  • Abbott

  • Merck KGaAA

  • Zoetis

  • Ortho Clinical Diagnostics

  • Getein Biotech, Inc.

  • HORIBA, Ltd

  • Randox Laboratories Ltd.

  • BODITECH MED, INC.

  • Aidian

Market Segmentation

  • Assay Type

    • Immunoturbidimetric Assay

    • ELISA

      • Clinical

      • Non-clinical

    • Chemiluminescence Immunoassay

    • Others

  • Detection Range

    • hs-CRP

    • Conventional CRP

    • cCRP

  • Disease Area

    • Cardiovascular Diseases

    • Cancer

    • Rheumatoid Arthritis

    • Inflammatory Bowel Disease

    • Endometriosis

    • Lupus

    • Others

  • End-use

    • Clinics

      • By Entity

        • Physician Offices

        • Small Clinics

        • Others

      • By Settings

        • Urban Setting

        • Rural Setting

    • Hospitals

      • Urban Setting

      • Rural Setting

    • Laboratories

      • Urban Setting

      • Rural Setting

    • Assisted Living Healthcare Facilities

      • Urban Setting

      • Rural Setting

    • Home

    • Others

  • Regional

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • China

      • Japan

    • Latin America

      • Brazil

    • Middle East and Africa (MEA)

      • South Africa

The C-reactive Protein Testing market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of C-reactive Protein Testing market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global C-reactive Protein Testing market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the C-reactive Protein Testing market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted C-reactive Protein Testing market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the C-reactive Protein Testing capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of C-reactive Protein Testing by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global C-reactive Protein Testing market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major C-reactive Protein Testing market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of C-reactive Protein Testing market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the C-reactive Protein Testing industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

C-reactive Protein Testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to C-reactive Protein Testing market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of C-reactive Protein Testing market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new C-reactive Protein Testing market. These factors have benefited the growth of the global market for C-reactive Protein Testing. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for C-reactive Protein Testing. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of C-reactive Protein Testing are as follows:

  • History Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:


- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

 

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global C-reactive Protein Testing Market, By Assay Type

7.1.  C-reactive Protein Testing Market, by Assay Type, 2021-2030

7.1.1.    Immunoturbidimetric Assay

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    ELISA

7.1.2.1.        Market Revenue and Forecast (2017-2030)

7.1.3.    Chemiluminescence Immunoassay

7.1.3.1.        Market Revenue and Forecast (2017-2030)

7.1.4.    Others

7.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global C-reactive Protein Testing Market, By Detection Range

8.1.  C-reactive Protein Testing Market, by Detection Range, 2021-2030

8.1.1.    hs-CRP

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Conventional CRP

8.1.2.1.        Market Revenue and Forecast (2017-2030)

8.1.3.    cCRP

8.1.3.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global C-reactive Protein Testing Market, By Disease Area

9.1.  C-reactive Protein Testing Market, by Disease Area, 2021-2030

9.1.1.    Cardiovascular Diseases

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Cancer

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Rheumatoid Arthritis

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Inflammatory Bowel Disease

9.1.4.1.        Market Revenue and Forecast (2017-2030)

9.1.5.    Endometriosis

9.1.5.1.        Market Revenue and Forecast (2017-2030)

9.1.6.    Lupus

9.1.6.1.        Market Revenue and Forecast (2017-2030)

9.1.7.    Others

9.1.7.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global C-reactive Protein Testing Market, By Capacitor

10.1.        C-reactive Protein Testing Market, by Capacitor, 2021-2030

10.1.1.  Clinics

10.1.1.1.      Market Revenue and Forecast (2017-2030)

10.1.2.  Hospitals

10.1.2.1.      Market Revenue and Forecast (2017-2030)

10.1.3.  Laboratories

10.1.3.1.      Market Revenue and Forecast (2017-2030)

10.1.4.  Assisted Living Healthcare Facilities

10.1.4.1.      Market Revenue and Forecast (2017-2030)

10.1.5.  Home

10.1.5.1.      Market Revenue and Forecast (2017-2030)

10.1.6.  Others

10.1.6.1.      Market Revenue and Forecast (2017-2030)

Chapter 11.      Global C-reactive Protein Testing Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.1.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.1.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.1.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.1.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.1.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.1.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.1.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.7.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.7.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.7.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.2.8.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.2.8.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.2.8.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.7.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.7.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.7.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.3.8.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.3.8.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.3.8.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.7.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.7.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.7.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.4.8.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.4.8.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.4.8.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.2.  Market Revenue and Forecast, by Detection Range (2017-2030)

11.5.3.  Market Revenue and Forecast, by Disease Area (2017-2030)

11.5.4.  Market Revenue and Forecast, by Capacitor (2017-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.5.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.5.5.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.5.5.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Assay Type (2017-2030)

11.5.6.2.      Market Revenue and Forecast, by Detection Range (2017-2030)

11.5.6.3.      Market Revenue and Forecast, by Disease Area (2017-2030)

11.5.6.4.      Market Revenue and Forecast, by Capacitor (2017-2030)

Chapter 12.  Company Profiles

12.1.              Thermo Fisher Scientific, inc.

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              F. Hoffmann-La Roche Ltd.

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Danaher

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              Quest Diagnostics

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Siemens Healthineers AG

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Abbott

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Merck KGaAA

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Zoetis

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              Ortho Clinical Diagnostics

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Getein Biotech, Inc.

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           HORIBA, Ltd

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

14.2.              Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers